Rhenman & Partners Asset Management AB as of March 31, 2020
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 85 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Horizon Therapeutics | 4.2 | $30M | 1.0M | 29.62 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.8 | $27M | 115k | 237.95 | |
| Abbvie (ABBV) | 3.5 | $25M | 330k | 76.19 | |
| Novocure Ltd ord (NVCR) | 3.4 | $24M | 360k | 67.34 | |
| UnitedHealth (UNH) | 2.8 | $20M | 80k | 249.38 | |
| Bristol Myers Squibb (BMY) | 2.7 | $20M | 350k | 55.74 | |
| Nektar Therapeutics (NKTR) | 2.7 | $19M | 1.1M | 17.85 | |
| Esperion Therapeutics (ESPR) | 2.6 | $19M | 593k | 31.53 | |
| Cigna Corp (CI) | 2.6 | $19M | 105k | 177.18 | |
| Boston Scientific Corporation (BSX) | 2.6 | $18M | 565k | 32.63 | |
| BioMarin Pharmaceutical (BMRN) | 2.2 | $16M | 185k | 84.50 | |
| CVS Caremark Corporation (CVS) | 2.2 | $15M | 260k | 59.33 | |
| Anthem (ELV) | 2.1 | $15M | 65k | 227.05 | |
| Alexion Pharmaceuticals | 2.0 | $14M | 160k | 89.79 | |
| Humana (HUM) | 2.0 | $14M | 45k | 314.02 | |
| Eli Lilly & Co. (LLY) | 1.9 | $14M | 100k | 138.72 | |
| Abbott Laboratories (ABT) | 1.9 | $13M | 170k | 78.91 | |
| Abiomed | 1.8 | $13M | 88k | 145.16 | |
| Merck & Co (MRK) | 1.8 | $13M | 165k | 76.94 | |
| Guardant Health (GH) | 1.7 | $12M | 175k | 69.60 | |
| Jazz Pharmaceuticals (JAZZ) | 1.7 | $12M | 120k | 99.74 | |
| Axonics Modulation Technolog (AXNX) | 1.7 | $12M | 465k | 25.41 | |
| Medtronic (MDT) | 1.6 | $12M | 131k | 90.18 | |
| Intuitive Surgical (ISRG) | 1.6 | $11M | 23k | 495.22 | |
| Neurocrine Biosciences (NBIX) | 1.6 | $11M | 130k | 86.55 | |
| Iovance Biotherapeutics (IOVA) | 1.5 | $11M | 365k | 29.93 | |
| Edwards Lifesciences (EW) | 1.5 | $11M | 57k | 188.61 | |
| Centene Corporation (CNC) | 1.5 | $10M | 175k | 59.41 | |
| Arena Pharmaceuticals | 1.4 | $10M | 240k | 42.00 | |
| Mirati Therapeutics | 1.4 | $10M | 130k | 76.87 | |
| Seattle Genetics | 1.4 | $9.8M | 85k | 115.38 | |
| Aerie Pharmaceuticals | 1.4 | $9.7M | 720k | 13.50 | |
| Xencor (XNCR) | 1.3 | $9.0M | 300k | 29.88 | |
| Alnylam Pharmaceuticals (ALNY) | 1.2 | $8.7M | 80k | 108.85 | |
| Intra Cellular Therapies (ITCI) | 1.2 | $8.7M | 568k | 15.37 | |
| Fibrogen (FGEN) | 1.2 | $8.7M | 250k | 34.75 | |
| Livanova Plc Ord (LIVN) | 1.2 | $8.6M | 190k | 45.25 | |
| Myokardia | 1.2 | $8.4M | 180k | 46.88 | |
| Zimmer Holdings (ZBH) | 1.1 | $8.1M | 80k | 101.08 | |
| Hca Holdings (HCA) | 1.1 | $8.1M | 90k | 89.86 | |
| Biogen Idec (BIIB) | 1.1 | $7.9M | 25k | 316.40 | |
| Immunomedics | 1.1 | $8.0M | 590k | 13.48 | |
| Cooper Companies | 0.9 | $6.6M | 24k | 275.67 | |
| Acceleron Pharma | 0.9 | $6.3M | 70k | 89.87 | |
| EXACT Sciences Corporation (EXAS) | 0.8 | $6.0M | 104k | 58.00 | |
| Macrogenics (MGNX) | 0.8 | $5.8M | 1.0M | 5.82 | |
| Alkermes (ALKS) | 0.8 | $5.8M | 399k | 14.42 | |
| Omnicell (OMCL) | 0.8 | $5.6M | 86k | 65.58 | |
| Silk Road Medical Inc Common (SILK) | 0.8 | $5.5M | 175k | 31.48 | |
| Epizyme | 0.8 | $5.4M | 350k | 15.51 | |
| Thermo Fisher Scientific (TMO) | 0.8 | $5.4M | 19k | 283.58 | |
| Adverum Biotechnologies | 0.8 | $5.4M | 550k | 9.77 | |
| Glaukos (GKOS) | 0.7 | $5.1M | 165k | 30.86 | |
| Biohaven Pharmaceutical Holding | 0.7 | $4.8M | 140k | 34.03 | |
| Sangamo Biosciences (SGMO) | 0.6 | $4.5M | 700k | 6.37 | |
| Agios Pharmaceuticals (AGIO) | 0.6 | $3.9M | 110k | 35.48 | |
| Radius Health | 0.5 | $3.8M | 295k | 13.00 | |
| Incyte Corporation (INCY) | 0.5 | $3.7M | 50k | 73.24 | |
| Dynavax Technologies (DVAX) | 0.5 | $3.5M | 1.0M | 3.53 | |
| Momenta Pharmaceuticals | 0.5 | $3.3M | 121k | 27.20 | |
| Revance Therapeutics (RVNC) | 0.5 | $3.3M | 220k | 14.80 | |
| Meiragtx Holdings (MGTX) | 0.5 | $3.3M | 246k | 13.44 | |
| Becton, Dickinson and (BDX) | 0.5 | $3.2M | 14k | 229.79 | |
| D Stemline Therapeutics | 0.4 | $3.1M | 650k | 4.84 | |
| Uniqure Nv (QURE) | 0.4 | $3.1M | 66k | 47.45 | |
| Bluebird Bio (BLUE) | 0.4 | $3.1M | 67k | 45.96 | |
| Ultragenyx Pharmaceutical (RARE) | 0.4 | $3.0M | 69k | 44.44 | |
| G1 Therapeutics (GTHX) | 0.4 | $2.8M | 250k | 11.02 | |
| Rigel Pharmaceuticals (RIGL) | 0.4 | $2.7M | 1.7M | 1.56 | |
| Apellis Pharmaceuticals (APLS) | 0.4 | $2.7M | 100k | 26.79 | |
| Intercept Pharmaceuticals In | 0.3 | $2.5M | 40k | 62.95 | |
| Beigene (BGNE) | 0.3 | $2.5M | 20k | 123.10 | |
| Aimmune Therapeutics | 0.3 | $2.4M | 165k | 14.42 | |
| Amarin Corporation (AMRN) | 0.3 | $2.2M | 550k | 4.00 | |
| Viewray (VRAYQ) | 0.3 | $2.1M | 850k | 2.50 | |
| Abeona Therapeutics | 0.3 | $2.0M | 950k | 2.10 | |
| Sage Therapeutics (SAGE) | 0.2 | $1.4M | 50k | 28.72 | |
| Cellectis S A (CLLS) | 0.2 | $1.3M | 145k | 9.20 | |
| Viking Therapeutics (VKTX) | 0.1 | $936k | 200k | 4.68 | |
| Pieris Pharmaceuticals (PIRS) | 0.1 | $684k | 300k | 2.28 | |
| Exxon Mobil Corporation (XOM) | 0.0 | $205k | 5.4k | 38.05 | |
| Chevron Corporation (CVX) | 0.0 | $215k | 3.0k | 72.29 | |
| International Business Machines (IBM) | 0.0 | $246k | 2.2k | 111.06 | |
| Ford Motor Company (F) | 0.0 | $141k | 29k | 4.83 | |
| Janus Henderson Group Plc Ord (JHG) | 0.0 | $163k | 11k | 15.31 |
